Ethical and Clinical Considerations in the Use of Hydroxyurea in Pregnant Women with Sickle Cell Disease

Hemoglobin. 2024 Jan;48(1):66-68. doi: 10.1080/03630269.2024.2310283. Epub 2024 Feb 7.

Authors

Gayatri Desai¹, Kapilkumar Dave¹, Sumeet Devare¹, Shrey Desai¹

Affiliation

¹ SEWA Rural, Jhagadia, India.

PMID: 38326997
DOI: 10.1080/03630269.2024.2310283

No abstract available

Keywords: Sickle cell disease; hydroxyurea; pregnancy.

MeSH terms

Anemia, Sickle Cell* / drug therapy
Antisickling Agents / therapeutic use
Female
Humans
Hydroxyurea* / therapeutic use
Pregnancy
Pregnant Women

Substances

Hydroxyurea
Antisickling Agents